Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins
- PMID: 2484703
Relaxations to SIN-1, nitric oxide, and sodium nitroprusside in canine arteries and veins
Abstract
Experiments were designed to compare the vasodilator properties of SIN-1, the active metabolite of molsidomine, with nitric oxide (NO) and sodium nitroprusside. Rings of canine femoral arteries and veins with and without endothelium were suspended in organ chambers for the measurement of isometric force. SIN-1 and sodium nitroprusside relaxed rings of blood vessels in the presence and in the absence of the endothelium. However, these relaxations were reduced by the endothelial cells in arteries contracted with endothelin and in veins contracted with prostaglandin F2 alpha. In the arteries, SIN-1, sodium nitroprusside, and NO were equipotent in relaxing rings without endothelium contracted with either norepinephrine or prostaglandin F2 alpha; NO was less potent than the other two vasodilators when the arteries were contracted with endothelin. In the veins without endothelium, the potency of the three nitrovasodilators was comparable; the veins were more sensitive to the effects of the dilators when contracted with prostaglandin F2 alpha than with either endothelin or norepinephrine. These results indicate that SIN-1, sodium nitroprusside, and NO are potent dilators of arterial and venous smooth muscle, and that the potency of the dilators can be altered by endothelial cells and the contractile agonist differentially in arteries and veins.
Similar articles
-
Effects of SIN-1 on isolated canine basilar arteries.J Cardiovasc Pharmacol. 1989;14 Suppl 11:S72-5. J Cardiovasc Pharmacol. 1989. PMID: 2484704
-
The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog.J Cardiovasc Pharmacol. 1993;22 Suppl 7:S10-6. J Cardiovasc Pharmacol. 1993. PMID: 7504762
-
Effects of SIN-1 on electrical responses of the smooth muscle of the canine saphenous vein.J Cardiovasc Pharmacol. 1989;14 Suppl 11:S62-6. J Cardiovasc Pharmacol. 1989. PMID: 2484702
-
[Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].Z Kardiol. 1991;80 Suppl 5:17-21. Z Kardiol. 1991. PMID: 1776330 Review. German.
-
[The pharmacology of nitric oxide and nitrates].Pharm Unserer Zeit. 2010 Sep;39(5):345-50. doi: 10.1002/pauz.201000379. Pharm Unserer Zeit. 2010. PMID: 20818683 Review. German. No abstract available.
Cited by
-
The role of nitric oxide in cardiac surgery.Surg Today. 1997;27(7):583-92. doi: 10.1007/BF02388212. Surg Today. 1997. PMID: 9306558 Review.
-
Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.Br J Clin Pharmacol. 1991 Sep;32(3):399-401. doi: 10.1111/j.1365-2125.1991.tb03919.x. Br J Clin Pharmacol. 1991. PMID: 1777378 Free PMC article. Clinical Trial.
-
Venous endothelial function in cardiovascular disease.Biosci Rep. 2022 Nov 30;42(11):BSR20220285. doi: 10.1042/BSR20220285. Biosci Rep. 2022. PMID: 36281946 Free PMC article.
-
Functional changes in nonadrenergic, noncholinergic inhibitory neurons in ileal circular smooth muscle after small bowel transplantation in rats.Dig Dis Sci. 1998 Nov;43(11):2446-54. doi: 10.1023/a:1026630115009. Dig Dis Sci. 1998. PMID: 9824132
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous